New injection aims to shed pounds in major obesity trial
NCT ID NCT07192263
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new injection called IN-B00009 to help adults with obesity or overweight lose weight. About 300 people will receive either the drug or a placebo for 40 weeks. The main goals are to see how much weight they lose and if the treatment is safe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Low-Calorie diet and Weight-Loss drug send type 2 diabetes into remission?
- Pedal-Assist E-Bikes may boost fitness and cut fat in sedentary students
- New program helps seniors in camden fight obesity and pain without drugs
- Exercise boosts Weight-Loss surgery results, study finds
- Obesity drug VCT220 put to the test: will common meds interfere?
- New obesity drug VCT220 put through drug interaction tests